These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

970 related items for PubMed ID: 29105558

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC, Ying KY, Yim CW, Siu YP, Tong KH, To CH, Ng WL.
    Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
    Choi CB, Won S, Bae SC.
    Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil or cyclophosphamide in indian patients with lupus nephritis: Which is better? A single-center experience.
    Mendonca S, Gupta D, Ali S, Gupta P.
    Saudi J Kidney Dis Transpl; 2017 May; 28(5):1069-1077. PubMed ID: 28937065
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus.
    Kawazoe M, Kaneko K, Yamada Z, Masuoka S, Mizutani S, Yamada S, Shikano K, Sato H, Kaburaki M, Muraoka S, Kawai S, Nanki T.
    Clin Rheumatol; 2019 Jun; 38(6):1571-1578. PubMed ID: 30778862
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis.
    Ikeuchi H, Hiromura K, Takahashi S, Mishima K, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Kuroiwa T, Nojima Y.
    Mod Rheumatol; 2014 Jul; 24(4):618-25. PubMed ID: 24252014
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome.
    Yap DY, Yu X, Chen XM, Lu F, Chen N, Li XW, Tang CS, Chan TM.
    Nephrology (Carlton); 2012 May; 17(4):352-7. PubMed ID: 22295934
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of tacrolimus versus mycophenolate mofetil as induction treatment and low-dose tacrolimus as treatment for lupus nephritis: a meta-analysis.
    Lee YH, Song GG.
    Z Rheumatol; 2023 Nov; 82(9):754-762. PubMed ID: 36607421
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunosuppressive treatment for proliferative lupus nephritis.
    Tunnicliffe DJ, Palmer SC, Henderson L, Masson P, Craig JC, Tong A, Singh-Grewal D, Flanc RS, Roberts MA, Webster AC, Strippoli GF.
    Cochrane Database Syst Rev; 2018 Jun 29; 6(6):CD002922. PubMed ID: 29957821
    [Abstract] [Full Text] [Related]

  • 16. Comparison of efficacy of continuous mycophenolate mofetil with sequential cyclophosphamide and tacrolimus as maintenance therapy for lupus nephritis.
    Kawazoe M, Nanki T.
    Lupus; 2024 Apr 29; 33(4):319-327. PubMed ID: 38232223
    [Abstract] [Full Text] [Related]

  • 17. Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH, Song GG.
    Lupus; 2015 Dec 29; 24(14):1520-8. PubMed ID: 26162684
    [Abstract] [Full Text] [Related]

  • 18. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
    Dittrich K, Ross S, Benz K, Amann K, Dötsch J.
    Klin Padiatr; 2009 Dec 29; 221(7):425-9. PubMed ID: 20013565
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.